Informazioni
Non ci sono recensioni
New Risk Factors of Cardiovascular Disease
Pages 3-19
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Controversies in Cardiology
Ambrose, Rodriguez
Editore
Springer
Anno
2015
Pagine
417
ISBN
9783319204147
100,00 €
This book will consider several clinical and interventional topics for which there is uncertainty, continued debate and/or no consensus based on current guidelines. While there are numerous guidelines in cardiology, new and on-going trials that address new drugs treatments and procedures raise many unanswered questions. Furthermore, most practicing cardiologist taking care of the patients are likely unable to digest all of these studies or guidelines and necessarily correctly apply them to their patients. If one considers in the guidelines the frequent use of Level C (consensus), there are many areas or situations where no trial exists. Also, when applying the results of a trial to an individual patient, there can be uncertainty of how this patient should be managed based on the present body of evidence.
-
-
Angiographic Narrowing Prior to ST Elevation MI. Are the Lesions Non Obstructive?
Pages 21-31
-
Vulnerable Plaques Versus Patients-How to Reduce Acute Coronary Events in the Future
Pages 33-42
-
Diabetes and Coronary Artery Disease
Pages 43-54
-
Elevated Triglycerides, Atherosclerosis and Adverse Clinical Events
Pages 55-67
-
Patent Foramen Ovale Closure and Stroke
Pages 69-79
-
CT Angiography Versus Routine Stress Testing for Patients with Chest Pain Seen in the Emergency Room to Exclude Significant Coronary Artery Disease
Pages 83-98
-
Takotsubo Cardiomyopathy – An Interesting and Somewhat Unexplained Clinical Entity
Pages 99-109
-
Chest Pain in Women: Evaluation and Management
Pages 111-132
-
Myocardial Infarction Diagnosis, Troponin Elevation and Angiographic Coronary Artery Disease
Pages 135-146
-
New Therapeutic Options for Patients with Refractory Angina
Pages 147-162
-
Medical and Invasive Management of Coronary Artery Disease in Patients on Anticoagulants
Pages 163-174
-
Managing Intracoronary Thrombus During PCI
Pages 175-185
-
Coronary Stenting Remains the First Revascularization Option in Most Patients with a Clinical Indication for Myocardial Revascularization
Pages 187-201
-
Optimal Management of Multivessel CAD: PCI Versus CABG Surgery Versus Medical Therapy Alone
Pages 203-219
-
Percutaneous Coronary Intervention in Unprotected Left Main Stenosis: Medical Evidence from Randomized and Observational Studies
Pages 221-236
-
Technical Aspects of Left Main Stem Percutaneous Coronary Intervention
Pages 237-253
-
DAPT After Stenting in Stable and Acute Coronary Syndromes- Does the Drug Combination Really Matter?
Pages 255-269
-
Invasive Management in CAD Patients with Stage 4 Renal Dysfunction or on Dialysis
Pages 271-285
-
What Is the Optimal Stent Design? – The Pathologist’s Opinion
Pages 287-305
-
What Is the Optimal Stent Design Interventionalist’s View
Pages 307-331
-
Role of Oral Therapies in the Prevention of Coronary Restenosis: Insights from Randomized Clinical Trials
Pages 333-347
-
When Should Ablation Be Considered in the Treatment of Atrial Fibrillation – A Clinician’s View
Pages 349-359
-
Radial and Femoral Access in Percutaneous Intervention
Pages 361-371
-
Advanced and Expensive Cardiovascular Procedures in the Very Elderly–Can We or Should We Limit Access?
Pages 373-384
-
Cost-Benefit of TAVR: Should Indications Be Expanded?
Pages 385-397
-
Editorial Comments on the Chapters
Pages 399-403
